APGRYAD — 2412432
Application number
2412432
Type(s)
Standard Characters
Category
Trademark
CIPO Status
SEARCHED
TM5 status
LIVE/APPLICATION/
Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
Filed
2025-07-18
Applicant
ASCENTAGE PHARMA (SUZHOU) CO., LTD.
68 XINQING ROAD, SUZHOU INDUSTRIAL PARK
SUZHOU
JIANGSU, 215000
CHINA
Agent
CPST INTELLECTUAL PROPERTY INC.
130 Queens Quay East
East Tower, Suite 809
Toronto,
ONTARIO M5A0P6
Documents
Index headings
- APGRYAD
Goods (Nice class & Statement)
- 5
- (1) Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; hemorrhoidal suppositories, laxative suppositories, and vaginal suppositories for the prevention and treatment of infections; medicated plasters; diagnostic preparations for medical purposes namely for use in cancer treatments; diagnostic biomarker reagents for medical purposes; Oil solutions for or use in the treatment of cancer and tumors; mineral food supplements; nutritional supplements for use in the treatment of cancer and tumors; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes for use in the treatment of cancer and tumors; Gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; solutions for contact lenses; media for bacteriological cultures; Depuratives for use in the treatment of cancer and tumors; veterinary preparations for use in the treatment of cancer and tumors; pesticides; sanitary napkins; dental abrasives; diapers for pets.
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2025-07-18 | ||
| Created | 2025-07-18 | ||
| Formalized | 2025-07-18 | ||
| Pre-Assessment Letter Sent | 2025-07-31 | Goods or Services Not Acceptable | |
| Search Recorded | 2026-04-14 | ||
| Examiner's First Report | 2026-04-14 | 2026-10-14 |